Avantor, Inc. (NYSE:AVTR – Free Report) – Equities research analysts at Zacks Research lowered their Q2 2026 earnings estimates for Avantor in a research report issued to clients and investors on Wednesday, May 20th. Zacks Research analyst Team now expects that the company will earn $0.19 per share for the quarter, down from their prior forecast of $0.20. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Avantor’s current full-year earnings is $0.79 per share. Zacks Research also issued estimates for Avantor’s Q3 2026 earnings at $0.20 EPS, FY2026 earnings at $0.78 EPS, Q1 2027 earnings at $0.19 EPS, Q1 2028 earnings at $0.22 EPS and FY2028 earnings at $0.91 EPS.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same period in the previous year, the company posted $0.23 earnings per share. The firm’s revenue for the quarter was up .0% on a year-over-year basis.
Read Our Latest Stock Report on AVTR
Avantor Stock Performance
AVTR opened at $7.87 on Thursday. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock’s 50 day moving average price is $7.95 and its two-hundred day moving average price is $9.91. The firm has a market capitalization of $5.37 billion, a P/E ratio of -9.71, a price-to-earnings-growth ratio of 4.41 and a beta of 0.94. Avantor has a 12-month low of $7.26 and a 12-month high of $15.93.
Hedge Funds Weigh In On Avantor
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its position in shares of Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC acquired a new position in Avantor in the second quarter worth about $32,000. Private Trust Co. NA raised its position in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares in the last quarter. Osaic Holdings Inc. lifted its stake in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after purchasing an additional 1,064 shares during the period. Finally, Los Angeles Capital Management LLC bought a new position in Avantor during the fourth quarter worth about $32,000. 95.08% of the stock is owned by institutional investors.
Insider Activity
In other news, Director Simon Dingemans acquired 25,000 shares of the stock in a transaction dated Friday, May 1st. The shares were acquired at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the completion of the transaction, the director owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gregory T. Lucier bought 10,000 shares of Avantor stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the transaction, the director owned 60,000 shares of the company’s stock, valued at $499,200. This trade represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 160,000 shares of company stock worth $1,287,950. Company insiders own 0.28% of the company’s stock.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Articles
- Five stocks we like better than Avantor
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
